The result was free publicity for Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy. (Mounjaro and Zepbound are manufactured by Eli Lilly, an American competitor to Novo.) ...

This helps reduce the amount of blood glucose in the bloodstream after eating. Mounjaro is similar to Ozempic, but it targets both GIP and GLP-1 receptors. Although they’re both effective for ...

Former speed skater Sarah Lindsay believes injections such as Ozempic and Mounjaro — known as GLP-1 drugs — are leaving users malnourished and vitamin-deficient. The 44-year-old celebrity ...

Credit: K KStock/Adobe Stock GLP-1 agonists—such as Ozempic, Mounjaro, and Wegovy—are reshaping the landscape of diabetes and obesity treatment. Originally developed for type 2 diabetes ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...